Elevate Advocacy provides strategic guidance to industry clients to ensure authentic and differentiated patient, caregiver and advocate leader engagement. We go beyond just gathering insights by elevating the role of the patient to key advisor on actionable business decisions.From building Patient Advocacy functions from the ground up to driving programmatic advancements, Elevate Advocacy ensures the reputation a company builds aligns with its values and ambitions.*Drives short-term and enduring patient engagement strategies for clinical-stage biotech looking to differentiate its drug development approach in a crowded competitive space. Leads strategic initiatives, including founding a global standing advisory committee in rare disease.*Coach "N of 1" industry advocacy leaders to effectively create and measure the impact of strategic initiatives for their organizations, while also effectively communicating their value to C-suite and Board of Directors.*Subject matter expert for Diversity Action Plans (DAPs). Authored high-impact, integrated DAPs for multiple pharma and biotech clients. Hired DEI staff and vendors to successfully create internal capacity and execute DAPs and DEI tactics in multiple indications.*Authored multiple presentations and articles on DEI planning to and for regulatory and clinical operations audiences.*Chief advisor and interim head of advocacy for clinical-stage biotech company interested in building an advocacy function to drive value for gene therapy asset. Hired and coached multiple employees.*Chief advisor for clinical-stage biotech focused on rare-disease biologics in highly diverse community settings. Provided counsel on patient-focused regulatory submissions, payor discussions, market research and corporate communications.*Won three, $10M+ studies for global CRO client. Created first-ever virtual event featuring 35+ Rare Disease leaders to engage in thought leadership around accessibility in Rare Disease clinical research.

*Formed global Caregiver Advisory Council within pediatric rare disease community where limited advocacy partners were available. Council provided valuable insights and solutions on topics and issues spanning: concerns of global families to enroll their children in first-in-human trials, the impact of travel for global families, how to create viable social contracts to ensure data integrity in trials.*Established relationships with five leading patient advocacy groups in SUNCT/SUNA and Trigeminal Neuralgia, when initial reports found "there were no advocacy partners in the rare pain and headache spaces." Created robust advocacy strategy and tactical plan to ensure enduring engagement, which would accelerate clinical trial recruitment, retention and insights gathering.*Established and led key processes and committees, including Expanded Access Program, Grants & Sponsorship Review Committee, and concept reviews with key internal stakeholders: Legal/Compliance, ELT, program leads, and clinical/medical leads. *Managed portfolio of vendors to expand advocacy function capacity, including BIPOC community outreach and engagement for Psychiatry Program, advisory board facilitation with Caregiver Advisory Council, company-wide and patient advocacy communications (quarterly newsletters, infographics, community statements), and company culture activities.*

*Developed U.S. advocacy strategy for Women's Health engagement *Championed diverse and inclusive advocacy engagement so that educational materials, commercial messaging, and clinical development information was representative of patient population*Built strong relationships with advocacy groups that had previously not worked with industry

*Led strategy development for U.S. postpartum depression patient advocacy function.*Developed hybrid advocacy model to identify, train, and manage internal Medical Affairs staff to expand advocacy function capacity.*Served as the 'face of Sage' to postpartum depression advocate community.*Cultivated and actively managed 200 relationships with maternal health advocates throughout the U.S.

* Led team of five advocacy professionals to accelerate clinical trial enrollment through leveraging patient advocacy group communication channels.* Developed department strategy to expand value Advocacy Relations provided to Continuum's business goals, study success, and client satisfaction.* Contributed to new business proposals to showcase how to successfully operationalize patient centricity in clinical research and through the product life cycle.* Integrated Advocacy Relations into other functional groups to provide more robust and comprehensive services.

*Led support group meeting presentations throughout the U.S. to inform activated patients about clinical research, specific studies, and collect patient experience data.*Engaged national patient advocacy groups and professional societies to increase awareness of and enrollment in clinical studies, specifically groups that were historically underrepresented in clinical research.*Conducted in-depth research to identify potential partnership opportunities between industry and advocacy groups.*Established new relationships and foster/manage existing relationships for long-term, high-value partnerships.*Collaborated with digital, project management, and other cross-functional stakeholders to develop comprehensive plans for clinical trial recruitment.*Incorporated the patient voice into clinical study development and outreach communications to increase patient engagement and study enrollment.

*Led matrix internal communications team focused on connecting therapeutic areas, functional groups, and regional offices to each other and cascading messaging to all Medical Affairs, Americas staff*Led cross-functional Planning Committee dedicated to organizing and developing content for annual domestic Medical Affairs conference*Managed matrixed operations team focused on executing annual global Medical Affairs meeting*Developed comprehensive communications strategies and tactics for department, including: weekly newsletter, quarterly Town Halls, annual meeting presentations, and periodic articles and announcements

*Co-chaired and organized the logistics for an innugural,180-person global medical affairs conference in Barcelona, Spain (March 2015).*Develop communications strategies to foster matrix organization information sharing, employee engagement, and innovation.*Execute communications plans and content for Medical Affairs and external stakeholders.*Communicate value of Medical Affairs provides to pharmaceutical industry and patients.*Plan and organize large-scale Medical Affairs conferences (domestic and international). This includes managing: $1M+ budgets, complex communications strategies with multiple work streams, logistics planning with outside vendors, site visits, production groups, etc.

*Conducted research and interviews for weekly business articles published on internal company website. These articles communicate the value of Independent Medical Education within the Scientific and Medical Affairs division, as well as the impact Medical Affairs has on Astellas.*Managed content for four different internal websites. Increased traffic to these websites by 40%.*Monitored and evaluated continuing medical education programs supported by Astellas' Independent Medical Education team. *Led committee dedicated to improving communication among team members within the Scientific and Medical Affairs division of Astellas. Within first year, committee successfully implmented four different initiatives to improve internal communication.*Subject matter expert on internal communications vehicles and practices.

* Served as a bridge between a major pharmaceutical client and advocacy groups within specific disease states: cardiovascular health and breast cancer.* Researched and monitored approximately 200 cardiovascular and ancillary health advocacy groups (obesity, pulmonary embolism, hypertension, etc.), identified major stakeholders, mapped out advocacy universe for each health group.* Recommended strategies for approaching over 90 cardiovascular advocacy groups based on stakeholder research and analysis.* Created exhaustive list of over 200 cardiovascular and ancillary health advocacy organizations, including budgetary information, scope of mission, organizational priorities, level of impact, and potential for industry collaboration.* Designed and edited presentations related to potential partnerships within the pharmaceutical industry and the cardiovascular health advocacy community.* Served as pharmaceutical client liaison at national advocacy conferences for breast cancer, including the San Antonio Breast Cancer Symposium in San Antonio, Texas and the Living Beyond Breast Cancer conference in Philadelphia, Pennsylvania.

* Researched grant rounds and project performance of over 60 countries awareded funding by the Global Fund.* Created database with comprehensive data on over 300 Global Fund programs, key contacts, and potential areas of interest to which IDLO could lend technical assistance.*Researched domestic funding opportunities for non-communicable diseases and HIV-specific infectious disease rule-of-law programs.

* Researched and authored the talking points and 1-page issue briefs used by HIV/AIDS advocates throughout Washington State at 2011 AIDS Awareness Lobby Day. * Selected to serve a leadership role on Lifelong AIDS Alliance’s Policy Advisory Team. * Organized Washington State AIDS Service Organizations to participate in biannual lobby day.* Helped generate consensus around talking points and legislative advocacy issues for biannual lobby day. * Authored a report recommending ways in which Lifelong could effectively position itself as a leader within the national HIV/AIDS landscape.* Conducted policy-specific research on HIV/AIDS program funding for a leading Washington State AIDS service organization (ASO). * Investigated potential federal funding sources and methods of fund delivery for ASOs via a prominent national AIDS coalition* Advocated to legislators in Washington State for increased funding for HIV/AIDS programs, services, as well as reproductive health education in public schools.

* Analyzed HIV/AIDS policy, lobbied legislators for appropriations money for HIV/AIDS research, prevention measures, and treatment programs. * Attended congressional briefings on health care issues and human rights issues. * Liaised on behalf of AIDS United at Federal AIDS Policy Partnership calls, Global AIDS Roundtable meetings, and other reproductive and safe sexual health advocacy meetings. * Drafted policy briefs and newsletter updates for member organizations.

* Facilitated continuous quality improvement (CQI) initiatives in the four busiest wards at Motebang Hospital (Lesotho's second largest district hospital).* Created communication strategies to keep staff updated on the latest developments in CQI.* Researched maternal mortality rates, care delivery trends, and wait times in over 5,000 patient charts.* Coordinated medical team's national and international accreditation efforts for LeBoHA's Family Medicine Training Program curriculum.